methylphenidate patch (Daytrana)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Charles Patrick Davis, MD, PhD
    Charles Patrick Davis, MD, PhD

    Charles Patrick Davis, MD, PhD

    Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.

GENERIC NAME: methylphenidate patch

BRAND NAME: Daytrana

DRUG CLASS AND MECHANISM: Methylphenidate is a medication used for treating attention deficit hyperactivity disorder (ADHD). It stimulates the central nervous system (CNS or brain) in a manner that is similar to amphetamines; however, its actions are milder than amphetamines. Amphetamines stimulate the brain by increasing the level of neurotransmitters, dopamine and norepinephrine, in the brain (neurotransmitters are chemicals produced by nerves that are released and attach to other nearby nerves as a means of communication among nerves). The exact mechanism of action of the drug in people with ADHD is unknown. Methylphenidate is the active ingredient in methylphenidate (Ritalin, Concerta), and also is available as pills and liquids. The FDA approved Methylphenidate patches in April 2006.



PREPARATIONS: Patch: 10 mg, 15 mg, 20 mg, and 30 mg strengths, delivering doses over 9 hours.

STORAGE: Store Methylphenidate patches between temperatures of 15 C and 30 C (59 F and 86 F). Do not store patches unpouched (outside of their container). Do not store patches in refrigerators or freezers. Once the sealed tray or outer pouch is opened, use contents within 2 months.

PRESCRIBED FOR: Methylphenidate transdermal patches are used for the treatment of attention deficit hyperactivity disorder (ADHD).

DOSING: The recommended dose for methylphenidate patches is to apply one 10 mg patch once daily for 9 hours for week 1, then increase to 15 mg patch for week 2, then increase to 20 mg patch for week 3, then increase to 30 mg patch for week 4 depending on response. The patch is applied to the hip area 2 hours before the effect is needed, and removed 9 hours after application. The dosing is for children aged 6 to 17.

Quick GuideADHD Symptoms in Children

ADHD Symptoms in Children
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Children's Health & Parenting Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors